Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 11.96% is 24% above its 5-year average of 9.62%, near the high end of its 5-year range (-24.49%–16.53%).
As of the fiscal period ended Tuesday, June 30, 2026. 12.09% below its 12-month average of 13.61%.
Reported quarterly EBITDA margin; no daily interpolation.
EBITDA MARGIN
11.96%
EBITDA MARGIN AVG TTM
13.61%
EBITDA MARGIN AVG 3Y
12.38%
EBITDA MARGIN AVG 5Y
9.62%
EBITDA MARGIN AVG 10Y
6.24%
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-12.09%
CURRENT VS 3Y AVG
-3.37%
CURRENT VS 5Y AVG
+24.33%
CURRENT VS 10Y AVG
+91.67%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$12.38B
EBITDA Margin
-11.84%
TTM Avg
-53.07%
3Y Avg
-52.51%
5Y Avg
-64.32%
Market Cap
$13.41B
EBITDA Margin
5.99%
TTM Avg
7.75%
3Y Avg
3.55%
5Y Avg
8.89%
Market Cap
$11.86B
EBITDA Margin
23.27%
TTM Avg
22.46%
3Y Avg
26.66%
5Y Avg
22.37%
Market Cap
$13.84B
EBITDA Margin
27.02%
TTM Avg
27.38%
3Y Avg
26.41%
5Y Avg
26.36%
Market Cap
$11.38B
EBITDA Margin
19.75%
TTM Avg
19.29%
3Y Avg
19.87%
5Y Avg
21.06%
Market Cap
$11.35B
EBITDA Margin
28.74%
TTM Avg
23.07%
3Y Avg
27.33%
5Y Avg
30.04%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Penumbra, Inc. (PEN) | $12.64B | 11.96% | 13.61% | 12.38% | 9.62% |
| Tempus AI, Inc. (TEM)vs › | $12.38B | -11.84% | -53.07% | -52.51% | -64.32% |
| Baxter International Inc. (BAX)vs › | $13.41B | 5.99% | 7.75% | 3.55% | 8.89% |
| Encompass Health Corporation (EHC)vs › | $11.86B | 23.27% | 22.46% | 26.66% | 22.37% |
| DaVita Inc. (DVA)vs › | $11.48B | 19.98% | 20.97% | 19.78% | 20.10% |
| The Cooper Companies, Inc. (COO)vs › | $13.84B | 27.02% | 27.38% | 26.41% | 26.36% |
| Exelixis, Inc. (EXEL)vs › | $13.89B | 38.84% | 34.03% | 26.26% | 22.70% |
| Align Technology, Inc. (ALGN)vs › | $11.38B | 19.75% | 19.29% | 19.87% | 21.06% |
| Bio-Techne Corporation (TECH)vs › | $11.35B | 28.74% | 23.07% | 27.33% | 30.04% |
| Globus Medical, Inc. (GMED)vs › | $11.13B | 20.41% | 18.54% | 20.94% | 21.85% |
Gross Margin
67.8%
EBITDA Margin
12.0%
Operating Margin
12.4%
Net Margin
10.7%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 11.96% |
| 2026-03-31 | 11.42% |
| 2025-12-31 | 16.53% |
| 2025-09-30 | 14.47% |
| 2025-06-30 | 13.65% |
| 2025-03-31 | 14.00% |
| 2024-12-31 | 14.95% |
| 2024-09-30 | 13.13% |
| 2024-06-30 | -24.49% |
| 2024-03-31 | 7.04% |
| 2023-12-31 | 14.78% |
| 2023-09-30 | 7.22% |
| 2023-06-30 | 9.41% |
| 2023-03-31 | 6.04% |
| 2022-12-31 | 5.10% |
| 2022-09-30 | 5.46% |
| 2022-06-30 | 2.78% |
| 2022-03-31 | 0.82% |
| 2021-12-31 | -16.81% |
| 2021-09-30 | 6.53% |
| 2021-06-30 | 7.52% |
| 2021-03-31 | 10.01% |
| 2020-12-31 | 1.03% |
| 2020-09-30 | -11.13% |
| 2020-06-30 | -13.81% |
| 2020-03-31 | 2.60% |
| 2019-12-31 | 8.88% |
| 2019-09-30 | 10.77% |
| 2019-06-30 | 10.98% |
| 2019-03-31 | 10.09% |
| 2018-12-31 | 6.94% |
| 2018-09-30 | -17.30% |
| 2018-06-30 | 9.88% |
| 2018-03-31 | 5.30% |
| 2017-12-31 | 5.26% |
| 2017-09-30 | 2.19% |
| 2017-06-30 | -0.69% |
| 2017-03-31 | -1.90% |
| 2016-12-31 | -0.91% |
| 2016-09-30 | -1.04% |
| 2016-06-30 | -0.10% |
| 2016-03-31 | 4.10% |
| 2015-12-31 | 4.31% |
| 2015-09-30 | 5.28% |
| 2015-06-30 | -8.05% |
| 2015-03-31 | 11.11% |
| 2014-12-31 | 1.56% |
| 2014-09-30 | 1.55% |
| 2014-06-30 | 2.23% |
| 2014-03-31 | 7.65% |
